140 related articles for article (PubMed ID: 7795142)
1. Do safety issues of plasma products constrain self-sufficiency?
Savidge GF
Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S67-70. PubMed ID: 7795142
[TBL] [Abstract][Full Text] [Related]
2. Is the unpaid/paid donation debate for better or for worse?--a commercial viewpoint.
Fischer J
Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S29-31. PubMed ID: 7795135
[TBL] [Abstract][Full Text] [Related]
3. Should clinical freedom be constrained in the name of self-sufficiency?
Schimpf K
Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S47-9. PubMed ID: 7795139
[TBL] [Abstract][Full Text] [Related]
4. Is self-sufficiency financially viable and ethically justifiable?--a commercial viewpoint.
Christie RB
Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S39-41. PubMed ID: 7795138
[TBL] [Abstract][Full Text] [Related]
5. Is self-sufficiency financially viable and ethically justifiable?--the role of the National Blood Authority.
Adey J
Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S35-6. PubMed ID: 7795136
[TBL] [Abstract][Full Text] [Related]
6. [Self-sufficiency in hemotherapy. Conditioning factors].
Barbolla L
Sangre (Barc); 1993 Dec; 38(6):463-71. PubMed ID: 8171382
[No Abstract] [Full Text] [Related]
7. Is self-sufficiency financially viable and ethically justifiable?--legal aspects.
Newdick C
Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S37-8. PubMed ID: 7795137
[TBL] [Abstract][Full Text] [Related]
8. Can the supply and demand for plasma-derived products ever be reconciled? Self-sufficiency from the viewpoint of a blood transfusion service.
Leikola J
Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S15-7. PubMed ID: 7795132
[TBL] [Abstract][Full Text] [Related]
9. Organizational changes in Canada.
Décary F
Vox Sang; 1998; 74 Suppl 2():527-9. PubMed ID: 9704494
[No Abstract] [Full Text] [Related]
10. European regulatory issues.
Betts J
Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S57-61. PubMed ID: 7795141
[TBL] [Abstract][Full Text] [Related]
11. Can the supply and demand for plasma-derived products ever be reconciled?
Kyburg LC
Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S19-21. PubMed ID: 7795133
[TBL] [Abstract][Full Text] [Related]
12. Is the unpaid/paid donation debate for better or for worse?--advantages of unpaid donations.
Contreras M
Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S27-8. PubMed ID: 7795134
[TBL] [Abstract][Full Text] [Related]
13. Romanian blood donors screening: is it really necessary and/or mandatory?
Hâţu G; Brumboiu MI; Gorgan IN; Bocşan IS
Rev Med Chir Soc Med Nat Iasi; 2013; 117(3):741-6. PubMed ID: 24502043
[TBL] [Abstract][Full Text] [Related]
14. [Transfusion safety].
Aprili G
Haematologica; 1991 Jun; 76 Suppl 3():385-94. PubMed ID: 1752537
[No Abstract] [Full Text] [Related]
15. The safety of blood components and derivatives.
Julius C; Westphal RG
Hematol Oncol Clin North Am; 1992 Oct; 6(5):1057-77. PubMed ID: 1400072
[TBL] [Abstract][Full Text] [Related]
16. Rethinking blood shield statutes in view of the hepatitis C pandemic and other emerging threats to the blood supply.
Rueda A
J Health Law; 2001; 34(3):419-58. PubMed ID: 11571894
[TBL] [Abstract][Full Text] [Related]
17. Is the gift still good? Examining the politics and regulation of blood safety in the European Union.
Farrell AM
Med Law Rev; 2006; 14(2):155-79. PubMed ID: 16831820
[No Abstract] [Full Text] [Related]
18. Blood safety.
Talib VH; Verma SK; Pandey J; Khurana SK
Indian J Pathol Microbiol; 1993 Apr; 36(2):170-5. PubMed ID: 8276484
[TBL] [Abstract][Full Text] [Related]
19. The European Blood Directive--its role in blood safety.
Seitz R
Dev Biol (Basel); 2007; 127():147-52. PubMed ID: 17486887
[TBL] [Abstract][Full Text] [Related]
20. Transposition of the Blood Directive into national law--the perspective of Portugal.
Gonçalves MH; Muon MC; Gonçalves Jd
Transfus Clin Biol; 2005 Feb; 12(1):18-20. PubMed ID: 15814287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
